Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine

General Hospital Psychiatry

Volumn 30, Issue 3, 2008, Pages 280-283

  Rostagno, Carlo ^a   Di Norscia, Gianni ^b   Placidi, Gian Framco ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Servizio di Psichiatria ASL 10   (Italy)

Author keywords

Blockers; Cardiotoxicity; Clozapine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CLOZAPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG WITHDRAWAL; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOKINESIA; HYPOKINETIC CARDIOMYOPATHY; MALE; SCHIZOPHRENIA; TREATMENT FAILURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIPSYCHOTIC AGENTS; CAPTOPRIL; CARBAZOLES; CLOZAPINE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL CONTRACTION; PROPANOLAMINES; PSYCHOTIC DISORDERS; TACHYCARDIA, SINUS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 42149131415     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2007.09.003     Document Type: Article

References (18)

1. Geddes J., Freemantle N., Harrison P., and Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321 (2000) 1371-1376
2. Meltzer H.Y., Alphs L., Green A.I., et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60 (2003) 82-91
3. Kapur S., and Remington G. Atypical antipsychotics. Patients value the lower incidence of extrapiramidal side effects. BMJ 321 (2000) 1360-1361
4. Kane J.M. Treatment-resistant schizophrenic patients. J Clin Psychiatry 57 Suppl 9 (1996) 35-40
5. Merril D.B., Dec G.W., and Goff D.C. Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 25 (2005) 32-41
6. Killian J.G., Kerr K., Lawrence C., and Celermajer D.S. Myocarditis and cardiomyopathy associated with clozapine. Lancet 354 (1999) 1841-1845
7. Jensen V.E., and Gotzsche O. Allergic myocarditis in clozapine treatment. Ugeskrift for Laeger 156 (1994) 4151-4152
8. Kane J., Honigfeld G., Singer J., et al. Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Arch Gen Psychiatry 45 (1988) 789-796
9. Reinders J., Parsonage W., Lange D., Potter J.M., and Plever S. Clozapine related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Austr NZ Psychiatry 38 (2004) 915-922
10. La Grenade L., Graham D., and Trontell A. Myocarditis and cardiomyopathy associated with clozapine in the United States. N Engl J Med 345 (2001) 224-225
11. Wehemeier P.M., Schuler-Springorum M., Heiser P., and Remschmidt H. Chart review for potential features of myocarditis in children and adolescents treated with clozapine. J Child Adolesc Psychopharmacol 14 (2004) 267-272
12. Committee on Safety of Medicine. Myocarditis and cardiomyopathy with antipsychotics: recent cases with clozapine (Clozaril). Currr Probl Pharmacovigilance 19 (1999) 9
13. Leo R.J., Kreger J.L., and Kim K.Y. Cardiomyopathy associated with clozapine. An Pharmacother 30 (1996) 603-605
14. Novartis Pharma Canada. Association of Clozaril (clozapine) with cardiovascular toxicity [Dear healthcare professional letter] 2002. Available at: http://www.hc-sc-gc-ca/hpfb-dgpsa/tdp-dpt/clozaril_e.pdf.
15. Wehemeier P.M., Heiser P., and Remschmidt H. Myocarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharmacol Ther 30 (2005) 91-96
16. Cohen H., Loeventhal U., Mutar M., and Koturr M. Association of autonomic dysfunction and clozapine heart rate variability and risk of sudden death in patients with schizophrenia on long-term psychotropic medications. Br J Pharmacol 179 (2001) 167-171
17. Fenelon G., Wijns W., Andries E., and Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 19 1 (1996) 95-106
18. Walker N.L., Cobbe S.M., and Birnie D.H. Tachycardiomyopathy: a diagnosis not to be missed. Heart 90 2 (2004) e7